Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo

Treatment targeting osteopontin (OPN) and monocyte chemoattractant protein 1 (MCP-1) has been recognized as a novel approach in renal crystal formation. The present study was designed to investigate the suppressive effects of metformin on nephrolithiasis formation and its potential mechanism. The cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiong, Yang, Tong, Li, Jie, Yang, Rui, Qi, Shiyong, Zhao, Yang, Li, Liang, Li, Jingjin, Zhang, Xuening, Yang, Kuo, Xu, Yong, Liu, Chunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414169/
https://www.ncbi.nlm.nih.gov/pubmed/30720053
http://dx.doi.org/10.3892/ijmm.2019.4084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414169/
https://www.ncbi.nlm.nih.gov/pubmed/30720053
http://dx.doi.org/10.3892/ijmm.2019.4084

Ejemplares similares